Wallachbeth capital announces bioaffinity technologies warrant inducement for aggregate gross proceeds of $1.4 million

Jersey city, n.j. , feb. 25, 2025 /prnewswire/ -- wallachbeth capital llc, a leading provider of capital markets and institutional execution services, announced today that bioaffinity technologies, inc. (nasdaq: biaf and biafw) has entered into warrant exercise agreements with three existing accredited investors to exercise certain outstanding warrants to purchase an aggregate of 2,438,473 of the company's shares of common stock (the "existing warrants").
BIAF Ratings Summary
BIAF Quant Ranking